| Financial Year |
March 31 2023 |
| Monetary Funds |
111,321,362.23 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
129,035,054.68 |
| Advances to Suppliers |
24,421,527.62 |
| Other Receivables |
12,862,943.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,102,739.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,622,819.63 |
| Total Current Assets |
416,800,838.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,700,470.96 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,947,772.27 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
25,239,107.17 |
| Total Assets |
442,039,945.30 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,000,000.00 |
| Accounts Payable |
1,784,803.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
349,202.64 |
| Taxes Payable |
280,920.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,822,745.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,825,423.88 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
62,214,078.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,267,454.07 |
| Total Liabilities |
85,481,532.88 |
| Paid-In Capital(Or Share Stock) |
1,232,470,000.00 |
| Capital Surplus |
1,801,022,674.88 |
| Surplus Reserve |
105,508,475.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,782,442,737.47 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
356,558,412.42 |
| Owner's Equity（Stockholder's Equity） |
356,558,412.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
442,039,945.30 |
